To provide information on the mechanism(s) by which TLR2 engagement can promote virus production, IM-MDDCs were either treated first with the TLR2 agonist prior to virus infection or, alternatively, pulsed first with HIV-1 before Pam3Csk4 treatment. Here, TLR2 is linked to viral infectious disease.